Nextrove Selects Evidex® Signal Management Platform by Advera Health Analytics

Share Article

Agreement will Enable Nextrove to Offer End-to-End Pharmacovigilance Software and Services

Nextrove, LLC. a global lifesciences system integrator focused exclusively on serving pharmaceutical and biotech organizations and Advera Health Analytics, Inc., a market leader in cloud based, software-as-a-service pharmacovigilance solutions, today announced an agreement that will enable Nextrove to integrate Advera Health’s Evidex®, a next generation drug safety signal detection and management platform, with it’s cutting edge pharmacovigilance solutions.

With this agreement, Nextrove will be able to accelerate drug safety decisions through technology built specifically for modern pharmacovigilance analytics and signaling. Nextrove’s clients will be able to leverage Evidex to manage safety signals, inquiries, and requests from detection through resolution, and elicit actionable intelligence from drug safety data.

“Increasing caseloads and new pressure to contribute to drug development and commercialization are emerging challenges for pharmacovigilance departments of all sizes. Finding the right partners to help us solve these challenges is one of our top priorities in 2020, said Brian Overstreet, President and CEO of Advera Health. “Nextrove’s strong experience with software deployments and integrations along with their deep knowledge of the pharmacovigilance, regulatory, and clinical affairs makes them an ideal partner to help drive adoption of Evidex”.

“After surveying the market for signal detection and management software, it was clear to us that Advera Health’s Evidex is the best solution to meet modern pharmacovigilance challenges and drive company-wide value from adverse event data and analytics perspective,“ said Anjani Jha, Founder and CEO at Nextrove. “With this agreement, we can now offer our clients an end-to-end signal management solution, building on our track record of 200 plus safety systems integrations.”

Since launching Evidex, Advera Health has been creating a next generation pharmacovigilance platform to connect disparate drug safety data sources and provide a user experience that elicits actionable intelligence from those data. The Evidex platform links to internal ICSR databases, FAERS, VigiBase, and other data and provides for a validated, audit ready environment to track and manage safety issues that are found in those data.

About Advera Health Analytics
Advera Health Analytics is a global leader in pharmacovigilance software, analytics, and data at the leading edge of drug safety science. Founded by a group of passionate healthcare entrepreneurs, Advera Health’s mission is to mitigate risk in the healthcare system by improving the transparency and actionability of drug safety data through the curation and aggregation of large disparate datasets and the application of advanced analytics and workflow.
Please visit http://www.adverahealth.com as well as our newsroom, blog, Twitter, and LinkedIn pages for more information about the company.

About Nextrove
Nextrove is a global Lifesciences Consulting and Product Development firm focused exclusively on serving Pharmaceutical and Biotech organizations. We take pride in being a premier yet nimble system integrator assisting our clients in Pharmacovigilance, Medical Information, Veeva, Salesforce, Enterprise Quality Management System (EQMS), RIM, Regulatory and Clinical Affairs and host of other services. Nextrove Lifesciences Solutions portfolio includes ProgressiveNEXT, ProgressiveCONVEY, ProgressiveMICC, GRRACE and ClinConnect.
Please visit http://www.nextrove.com as well as our LinkedIn page for more information about the company.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Brian Overstreet
@AdveraHealth
Follow >
Visit website